Michael Barbella, Managing Editor05.18.24
New products and personnel won over ODT website visitors this past week.
New product updates came from Sonex Health Inc., FX Shoulder, and Exactech. Leading the charge was Sonex Health, which drove site traffic by announcing it has initiated its MISSION trial (Post-Market RegIStry of the Patient Experience when uSing UltraGuIdeCTR fOr Carpal TuNnel Release), which aims to assess carpal tunnel treatment. MISSION is designed to be the largest U.S. multi-center clinical study of its kind. It will collect real-world, long-term data on carpal tunnel syndrome (CTS) patients treated with a carpal tunnel release (CTR) procedure using Sonex Health’s device—UltraGuideCTR—which employs real-time ultrasound guidance (CTR-US).
FX Shoulder, meanwhile, amassed pageviews for earning FDA 510(k) clearance for six new full-wedge, augmented glenoid baseplates. There are now 18 glenoid baseplates in the company’s portfolio. All baseplates are 24 mm in diameter and have full-wedge options at 7.5° and 15° as well as options to lateralize 0, +3, or +6 mm, according to the company. They have four peripheral screw holes with 12° of polyaxial variability that can be fixed with 4.5 mm standard or locking screws.
Exactech concurrently enticed cybervisitors by unveiling new ExactechGPS software that offers patient-centric planning and modern alignment philosophies for total knee replacement. The software release upgrades the company’s Newton knee balancing technique. It lets surgeons simultaneously plan femur and tibia resections by using intra-operative ligament laxity and alignment data.
Lincoteck and Orthofix coaxed ODT loyalists to the site as well with personnel updates: The former named Anthony (Tony) Gascon as head of Global Operational Excellence of the Group and general manager of Lincotek Medical U.S. Casting and Machining, while the latter added Lucas Vitale to its ranks as chief People and Business Operations officer.
New product updates came from Sonex Health Inc., FX Shoulder, and Exactech. Leading the charge was Sonex Health, which drove site traffic by announcing it has initiated its MISSION trial (Post-Market RegIStry of the Patient Experience when uSing UltraGuIdeCTR fOr Carpal TuNnel Release), which aims to assess carpal tunnel treatment. MISSION is designed to be the largest U.S. multi-center clinical study of its kind. It will collect real-world, long-term data on carpal tunnel syndrome (CTS) patients treated with a carpal tunnel release (CTR) procedure using Sonex Health’s device—UltraGuideCTR—which employs real-time ultrasound guidance (CTR-US).
FX Shoulder, meanwhile, amassed pageviews for earning FDA 510(k) clearance for six new full-wedge, augmented glenoid baseplates. There are now 18 glenoid baseplates in the company’s portfolio. All baseplates are 24 mm in diameter and have full-wedge options at 7.5° and 15° as well as options to lateralize 0, +3, or +6 mm, according to the company. They have four peripheral screw holes with 12° of polyaxial variability that can be fixed with 4.5 mm standard or locking screws.
Exactech concurrently enticed cybervisitors by unveiling new ExactechGPS software that offers patient-centric planning and modern alignment philosophies for total knee replacement. The software release upgrades the company’s Newton knee balancing technique. It lets surgeons simultaneously plan femur and tibia resections by using intra-operative ligament laxity and alignment data.
Lincoteck and Orthofix coaxed ODT loyalists to the site as well with personnel updates: The former named Anthony (Tony) Gascon as head of Global Operational Excellence of the Group and general manager of Lincotek Medical U.S. Casting and Machining, while the latter added Lucas Vitale to its ranks as chief People and Business Operations officer.